Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gil I Wolfe

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Annals of the New York Academy of Sciences|November 1, 2003
Development of a thymectomy trial in nonthymomatous myasthenia gravis patients receiving immunosuppressive therapyGil I Wolfe, Henry J Kaminski, Alfred Jaretzki, et al.
Acta Neurologica Scandinavica|June 16, 2021
Validation of Spanish version of 15-item myasthenia gravis quality-of-life questionnaireJuan Pablo Contreras, Rodrigo Salinas, Carolina Vidal, et al.
Journal of the Neurological Sciences|November 26, 2019
Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?Jeffrey A Allen, Deborah F Gelinas, Miriam Freimer, et al.
Muscle & Nerve|November 18, 2010
The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravisTed M Burns, C K Grouse, Gil I Wolfe, et al.
Neurology|January 16, 2004
Benefit of IVIg for long-standing ataxic sensory neuronopathy with Sjögren's syndromeGil I Wolfe, Sharon P Nations, Dennis K Burns, et al.
Journal of Clinical Neuromuscular Disease|September 3, 2010
Isolated neck extensor myopathy: is it responsive to immunotherapy?Srikanth Muppidi, David S Saperstein, Aziz Shaibani, et al.
Muscle & Nerve|February 24, 2015
Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United StatesTed M Burns, Donald B Sanders, Henry J Kaminski, et al.
Journal of the Neurological Sciences|November 4, 2011
Implementing clinical trials on an international platform: challenges and perspectivesGreg Minisman, Minal Bhanushali, Robin Conwit, et al.
Journal of the Neurological Sciences|September 26, 2021
IgG regulation through FcRn blocking: A novel mechanism for the treatment of myasthenia gravisGil I Wolfe, E Sally Ward, Hans de Haard, et al.
Plos One|October 10, 2023
Serum metabolomics of treatment response in myasthenia gravisPatricia Sikorski, Yaoxiang Li, Mehar Cheema, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Annals of the New York Academy of Sciences|November 1, 2003
Development of a thymectomy trial in nonthymomatous myasthenia gravis patients receiving immunosuppressive therapyGil I Wolfe, Henry J Kaminski, Alfred Jaretzki, et al.
Acta Neurologica Scandinavica|June 16, 2021
Validation of Spanish version of 15-item myasthenia gravis quality-of-life questionnaireJuan Pablo Contreras, Rodrigo Salinas, Carolina Vidal, et al.
Journal of the Neurological Sciences|November 26, 2019
Immunoglobulin administration for the treatment of CIDP: IVIG or SCIG?Jeffrey A Allen, Deborah F Gelinas, Miriam Freimer, et al.
Muscle & Nerve|November 18, 2010
The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravisTed M Burns, C K Grouse, Gil I Wolfe, et al.
Neurology|January 16, 2004
Benefit of IVIg for long-standing ataxic sensory neuronopathy with Sjögren's syndromeGil I Wolfe, Sharon P Nations, Dennis K Burns, et al.
Journal of Clinical Neuromuscular Disease|September 3, 2010
Isolated neck extensor myopathy: is it responsive to immunotherapy?Srikanth Muppidi, David S Saperstein, Aziz Shaibani, et al.
Muscle & Nerve|February 24, 2015
Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United StatesTed M Burns, Donald B Sanders, Henry J Kaminski, et al.
Journal of the Neurological Sciences|November 4, 2011
Implementing clinical trials on an international platform: challenges and perspectivesGreg Minisman, Minal Bhanushali, Robin Conwit, et al.
Journal of the Neurological Sciences|September 26, 2021
IgG regulation through FcRn blocking: A novel mechanism for the treatment of myasthenia gravisGil I Wolfe, E Sally Ward, Hans de Haard, et al.
Plos One|October 10, 2023
Serum metabolomics of treatment response in myasthenia gravisPatricia Sikorski, Yaoxiang Li, Mehar Cheema, et al.
Pageof 11